Many aggregation-induced emission (AIE) systems exhibit broad and structureless luminescence emission spectra resembling the Gaussian distribution, which is likely due to kinetically locked molecular conformers in the condensed phase. To verify the hypothesis, a series of tetraphenylethene (TPE) derivatives are synthesized and characterized as aqueous nanoparticle suspensions. It is found that the unsubstituted TPE exhibits reduced fluorescence intensity accompanied by a blueshift of the emission maximum, after the temperature of the aqueous suspension is elevated and cooled to room temperature again. For a naphthalimide-substituted TPE compound, thermal treatment of the AIE aqueous suspension results in complete, irreversible aggregation-caused quenching (ACQ) of fluorescence, which can be restored by a redissolving-precipitation process of thermally treated aggregates. The phenomenon is ascribed as a relative population shift of a kinetic AIE (k-AIE) state to a thermodynamic AIE (t-AIE) or ACQ state, evidenced by differential scanning calorimetry, dynamic light scattering, and scanning electron microscopy. The phenomenon may be universal for many other AIE systems and could be explored as stimuli-responsive materials.

Lipid nanovesicles (LNVs) and polymer nanovesicles (PNVs), also known as liposomes and polymersomes, are becoming increasingly vital in global health. However, the two major classes of nanovesicles both exhibit their own issues that significantly limit potential applications. Here, by covalently attaching a naturally occurring phosphate "lipid head" and a synthetic polylactide "polymer tail" via facile ring-opening polymerization on a 500 g scale, a type of "chimeric" nanovesicles (CNVs) can be easily produced. Compared to LNVs, the reported CNVs exhibit reduced permeability for small and large molecules; on the other hand, the CNVs are less hydrophobic and exhibit enhanced tolerance toward proteins in buffer solutions without the need for hydrophilic polymeric corona such as poly(ethylene glycol)(PEG), in contrast to conventional PNVs. The proof-of-concept in vitro delivery experiments using hydrophilic solutions of fluorescein-PEG, rhodamine-PEG, and anti-cancer drug doxorubicin demonstrate that these CNVs, as a structurally diverse class of nano-materials, are highly promising as alternative carriers for therapeutic molecules in translational nanomedicine.

Lipid nanovesicles (LNVs) and polymer nanovesicles (PNVs), also known as liposomes and polymersomes, are becoming increasingly vital in global health. One recent example is the widely distributed mRNA Covid-19 vaccines. However, the two major classes of nanovesicles both exhibit their own issues that significantly limit potential applications. Here, by covalently attaching a naturally occurring phosphate “lipid head” and a synthetic polylactide “polymer tail” via facile ring-opening polymerization on a 500-gram scale, a type of “chimeric” nanovesicles (CNVs) can be easily produced. Compared to LNVs, the reported CNVs exhibit reduced permeability for small and large molecules; on the other hand, the CNVs are less hydrophobic and exhibit enhanced tolerance toward proteins in buffer solutions without the need for hydrophilic polymeric corona such as poly(ethylene glycol), in contrast to conventional PNVs. The proof-of-concept in vitro delivery experiments using hydrophilic solutions of fluorescein-PEG, rhodamine-PEG, and anti-cancer drug doxorubicin demonstrate that these CNVs, as a structurally diverse class of nano-materials, are highly promising as alternative carriers for therapeutic molecules in translational nanomedicine.